SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Aug. 4, 2006--Medistem Laboratories, Inc. (OTCBB:MDSM - News; FWB:S2U), committed to the ethical development of next-generation medical therapies from non-controversial adult stem cell sources, has filed a patent application with the United States Patent and Trademark Office for a potential stem cell therapy for erectile dysfunction (ED).
